Overview

A Long Term Safety Extension Study (CHS-0214-05)

Status:
Completed

Trial end date:
2017-10-01

Target enrollment:

Participant gender:

Summary

An Open-label, Safety Extension Study (OLSES) evaluating the longer-term safety and durability of response of subjects who completed 48 weeks of evaluations in the confirmatory safety and efficacy studies, CHS 0214-02 or CHS-0214-04, evaluating CHS-0214 in patients with rheumatoid arthritis (RA) and plaque psoriasis (PsO), respectively.

Phase:

Phase 3

Details

Lead Sponsor:

Coherus Biosciences, Inc.

Collaborators:

Baxalta US Inc.
Daiichi Sankyo Co., Ltd.
Shire